Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

INSYS Therapeutics Inc (NASDAQ:INSY)

32.42
Delayed Data
As of Aug 31
 -1.41 / -4.17%
Today’s Change
15.45
Today|||52-Week Range
46.17
+53.80%
Year-to-Date
No recent news for INSYS Therapeutics Inc.

Today’s Trading

Previous close33.83
Today’s open33.58
Day’s range32.30 - 34.04
Volume530,554
Average volume (3 months)909,889
Market cap$2.4B
Dividend yield--
Data as of 4:14pm ET, 08/31/2015

Growth & Valuation

Earnings growth (last year)-26.06%
Earnings growth (this year)-5.86%
Earnings growth (next 5 years)+28.00%
Revenue growth (last year)+123.72%
P/E ratio66.7
Price/Sales6.96
Price/Book14.44

Competitors

 Today’s
change
Today’s
% change
GWPHGW Pharmaceuticals P...-3.03-2.77%
MYGNMyriad Genetics Inc+1.13+3.10%
GLPGGalapagos NV+0.09+0.15%
CMRXChimerix Inc-1.54-3.05%
Data as of 3:59pm ET, 08/31/2015

Financials

Next reporting dateNovember 10, 2015
EPS forecast (this quarter)$0.25
Annual revenue (last year)$222.1M
Annual profit (last year)$38.0M
Net profit margin17.10%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael L. Babich
Chief Financial &
Accounting Officer
Darryl S. Baker
Corporate headquarters
Chandler, Arizona

Forecasts

Partner Offers